PTCT logo

PTC Therapeutics Inc

PTCT

$31.91

+ $7.55 (30.94%) This month

Closed: 1 Mar 2024 21:00 US/Eastern

Key details

CEO

Stuart Peltz

Employees

1,467

Headquarters

South Plainfield, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About PTC Therapeutics Inc

ptc is biopharmaceutical company focused on the discovery and development of orally-administered, proprietary small molecule drugs that target post-transcriptional control processes. while ptc’s discovery programs are directed at targets in multiple therapeutic areas, ptc is focusing particularly on the development and commercialization of treatments for orphan and ultra-orphan disorders. post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. ptc’s internally-discovered pipeline addresses multiple therapeutic areas, including neuromuscular disorders, oncology and infectious diseases. for more information on the company, please visit our website www.ptcbio.com.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG